- AI-supported screening resulted in 12% fewer interval cancers and 16% fewer invasive interval cancers vs standard screening.
- Sensitivity was 81% in the AI group vs 74% in the control group, with the improvement consistent across age and breast density for invasive cancer but not for in-situ cancer.
- Specificity remained at 99% for both groups, while screen reading workload was reduced by 44% with AI support.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
